Royalty War

New York University has filed a lawsuit against Pfizer in an effort to collect royalty payments it says the pharma firm owes it for a lung cancer drug and diagnostic kit, according to PharmaLive.

NYU says Pfizer owes royalties on a drug called Xalkori, a receptor tyrosine kinase inhibitor that FDA cleared two years ago to treat non-small cell lung cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.